| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +72.1K | 100% | $1.68 | +$121K |
| Sells | 0 | ||||
| Net | +2 | +72.1K | 100% | +$121K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rory B. Riggs | Director | $761K | May 26, 2021 | ||
| Enrique A. Conterno | Chief Executive Officer, Director | $306K | Jul 7, 2023 | ||
| Pat Cotroneo | Executive Advisor & Former CFO | $209K | Sep 7, 2021 | ||
| Thomas F. Kearns Jr | Director | $190K | Sep 15, 2021 | ||
| Thane Wettig | CEO, Director | $165K | +$95.5K | +137% | Sep 6, 2024 |
| Mark Eisner | EVP, Chief Medical Officer | $122K | Sep 6, 2023 | ||
| Christine Chung | Svp, China Operations | $119K | Sep 6, 2024 | ||
| Deyaa Adib | Chief Medical Officer | $96.1K | +$25.9K | +36.9% | Jun 12, 2024 |
| Juan Graham | Chief Financial Officer | $65.3K | Sep 6, 2024 | ||
| Gerald Lema | Director | $34.5K | Jun 5, 2024 | ||
| Kalevi Kurkijarvi | Director | $28.7K | May 26, 2021 | ||
| Jeffrey L. Edwards | Director | $25.8K | Jun 5, 2024 | ||
| Maykin Ho | Director | $23.9K | Jun 5, 2024 | ||
| Suzanne Blaug | Director | $22.5K | Jun 5, 2024 | ||
| Jeffrey William Henderson | Director | $21.9K | Sep 1, 2023 | ||
| Benjamin Cravatt | Director | $21.8K | Jun 5, 2024 | ||
| Aoife Brennan | Director | $21.2K | Jun 5, 2024 | ||
| James A. Schoeneck | Director | Jun 5, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|